Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder [Phase 4]
This Phase 4 clinical trial update reports on how stimulant medications influence brain processes involved in decision making in people with…
-
FDA approval · 2015-11-23FDA Approved: DEXTROAMPHETAMINE SULFATE — Original Application (KVK-Tech, Inc.)
FDA approved a generic version of dextroamphetamine sulfate under an Original Application for KVK-Tech, Inc., making this product available …
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Risk Perception in Adults With Attention Deficit and Hyperactivity Disorder (ADHD)
This clinical trial update summarizes results from a completed study examining risk perception in adults with Attention-deficit/hyperactivit…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Effect of Feedback and Practice on Probabilistic Decision Making in Attention Deficit and Hyperactivity Disorder [NA]
Completed clinical trial evaluating how feedback and practice influence probabilistic decision making in individuals with attention-deficit/…
-
FDA approval · 2015-11-17FDA Approved: METHAMPHETAMINE HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s generic methamphetamine hydrochloride tablets under an original ANDA; indications include atte…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-11-13FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' generic methylphenidate hydrochloride product via Original Application, making a generic version of meth…
-
FDA approval · 2015-11-09FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
The FDA approved a supplemental NDA for the Methylphenidate Transdermal System (methylphenidate) from PADAGIS US LLC, enabling a new transde…
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: Comparative Effectiveness of Primary Care-based Interventions for Pediatric ADHD [NA]
This clinical trial update notes the completion of a comparative effectiveness study evaluating primary care-based interventions for pediatr…
-
FDA approval · 2015-10-23FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Teva’s generic product containing four amphetamine salt components (dextroamphetamine saccha…
-
FDA approval · 2015-10-19FDA Approved: DYANAVEL XR — Original Application (NextWave Pharmaceuticals, Inc)
FDA approved DYANAVEL XR (amphetamine extended-release) from NextWave Pharmaceuticals as a new treatment for attention-deficit/hyperactivity…
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Combination Natural Health Product in Children With Attention Deficit/Hyperactivity Disorder (ADHD) [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluated a combination natural health product for children with Attention Deficit Hyperactivity …
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Near Infrared Spectroscopy Neurofeedback Training for ADHD [NA]
This document provides a status update on a clinical trial evaluating near-infrared spectroscopy neurofeedback for attention-deficit/hyperac…
-
FDA label_change · 2015-10-13FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for clonidine hydrochloride by Actavis Pharma, Inc., indicating changes to the approved product …
-
CLINICAL_TRIALS trial_result · 2015-09-29Clinical Trial Update: Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA) [Phase 4]
Phase 4 update reporting completion of the Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA). The t…
-
FDA approval · 2015-09-29FDA Approved: METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Original Application (SpecGx LLC)
FDA approved a methylphenidate hydrochloride extended-release generic from SpecGx LLC under an Original Application (ANDA).
-
FDA approval · 2015-09-24FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' dexmethylphenidate hydrochloride as an original generic product for the treatment of attention-d…
-
FDA approval · 2015-09-22FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Camber Pharmaceutical Inc)
The FDA approved Camber Pharmaceutical's methylphenidate hydrochloride as an Original Application, providing a generic version of the stimul…
-
FDA approval · 2015-09-15FDA Approved: APTENSIO XR — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for Aptensio XR (methylphenidate hydrochloride) by Rhodes Pharmaceuticals L.P., resulting in a label…
-
CLINICAL_TRIALS research · 2015-09-10Clinical Trial Update: Effects of a Probiotic Supplement on Symptoms of Attention Deficit Hyperactivity Disorder and Anxiety in Children [Phase 4]
Phase 4 clinical trial evaluating a probiotic supplement for symptoms of attention-deficit/hyperactivity disorder and anxiety in children; c…
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: The Effect of Physical Effort in the Decision Making Process of Preadolescents With ADHD
A completed clinical trial examining how physical effort influences decision-making in preadolescents with ADHD.
-
CLINICAL_TRIALS research · 2015-09-09Clinical Trial Update: Based-virtual Reality Diagnosis for Neuropsychiatric Diseases and Sleep/Wake Disorders [NA]
The document describes a clinical trial evaluating VR-based diagnosis for neuropsychiatric and sleep/wake disorders, including ADHD, addicti…
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia and Bipolar Disorder
A completed clinical trial evaluated auditory brainstem response as a diagnostic tool for schizophrenia and bipolar disorder.
-
FDA approval · 2015-08-25FDA Approved: ATOMOXETINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for a generic atomoxetine product by Zydus Pharmaceuticals USA Inc. The product is indicated for the…
-
FDA approval · 2015-08-20FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Actavis's generic dextroamphetamine/amphetamine salt product. The approval updates labeling and …
-
CLINICAL_TRIALS research · 2015-08-19Clinical Trial Update: Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy [Phase 3]
Phase 3 clinical trial evaluating cortical excitability phenotype and biomarkers in attention-deficit/hyperactivity disorder. Current status…